LGALS9 and neoplasm: Similarly, combined treatment again with anti-Gal-9 (RG9-1) and AZD1390, an inhibitor of the ataxia telangiectasia mutated (ATM) kinase essential for DNA damage responses, synergistically reduced CT26 tumor growth in BALB/c mice and progression of even poorly immunogenic tumors [228].